The GLP-1 receptor arm drives glucose-dependent insulin secretion alongside suppression of pancreatic alpha-cell glucagon output, slows gastric emptying, and engages central nervous system appetite-modulating circuits in the hypothalamus and brainstem (PMID 39515565)
It is recommended to verify with your insurance provider whether they cover GLP-1 medications
These drugs share some similarities, such as side effects and warnings, but they also have some differences, such as in their uses, formulations, and doses
World Health Organization, Geneva
Unlike GHRP-6, which is known for causing intense hunger, Ipamorelin has a negligible effect on appetite
Chronic pancreatitis and pancreatic cancer risk: a systematic review and meta-analysis